Table 1. HTS Cluster 1 and Singleton hits.
| Leadscope Grouping | PubChem SID | PubChem Bioassay Activity1 | IC50 (µM) Resupply | % Inhibition of hGlck (10 µM) | BSF EC50 (µM) | % PF Growth Inhibition (10 µM) | L. major EC50 (µM) |
| Cluster 1 | 856002 (Ebselen) | 344/44/22 | 0.05±0.03 | 97.8±0.1 | 2.9±0.28 | 51±0.16 | 4.1±0.4 |
| 17387000 | 236/38/17 | 2.0±0.5 | 6.7±9.4 | 0.030±0.067 | 48±0.15 | 1.9±0.2 | |
| 24785302 | 170/21/11 | 4.2±1.0 | 6.9±4.2 | 0.042±0.0028 | 47±0.15 | 1.9±0.2 | |
| 3716597 | 318/29/18 | 9.3±0.3 | 7.8±7.1 | >10 | 27±0.080 | >12.5 | |
| 24830882 | 171/12/7 | 16.9±0.1 | 88.8±4.9 | 0.83±0.20 | 8.6±0.030 | >12.5 | |
| 16952891 | 214/24/11 | 2.6±0.2 | 44.9±9.9 | 0.30±0.079 | 47±0.15 | >12.5 | |
| Singletons | 22401406 | 184/5/2 | 2.3±0.3 | 0.0 | >10 | 0.0 | >12.5 |
| 24797131 | 175/6/2 | 11.4±3.2 | 6.3±8.8 | >10 | 0.0 | >12.5 | |
| 17386310 | 211/10/4 | 33.6±10.2 | 70.3±3.6 | 0.038±0.0038 | 50±0.15 | 2.6±0.1 | |
| 14728414 | 216/2/1 | 41.7±3.0 | 1.9±7.0 | >10 | 0.0 | >12.5 |
1
As of 09/03/09. Number of bioassays in which the compound was tested/number in which the compound was active/number in which the compound has been confirmed as an inhibitor.